Latest news
Supernus & Indivior to merge in $2.2 billion CNS pharma deal - Voice of HealthcareVoice of Healthcare · Tue, 04 Aug 2026 06:09:03 GMTBiocon gets Health Canada nod for Yesintek autoinjector pen - The Economic TimesThe Economic Times · Wed, 29 Jul 2026 07:00:00 GMTBiocon Wins Health Canada Approval for Yesintek Autoinjector - Voice of HealthcareVoice of Healthcare · Wed, 29 Jul 2026 07:00:00 GMTBiocon Wins Health Canada Approval for Yesintek Ustekinumab Autoinjector Pen - TipRanksTipRanks · Wed, 29 Jul 2026 05:09:30 GMTBiocon gets Canada government’s nod for Yesintek autoinjector to treat autoimmune diseases - financialexpress.comfinancialexpress.com · Wed, 29 Jul 2026 05:05:54 GMT